Impact of renin–angiotensin–aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study

BACKGROUND: The influence of renin–angiotensin–aldosterone system (RAAS) inhibitors on the critically ill COVID-19 patients with pre-existing hypertension remains uncertain. This study examined the impact of previous use of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Kei, White, Nicole, Fanning, Jonathon P., Obonyo, Nchafatso, Yamashita, Michael H., Appadurai, Vinesh, Ciullo, Anna, May, Meryta, Worku, Elliott T., Helms, Leticia, Ohshimo, Shinichiro, Juzar, Dafsah A., Suen, Jacky Y., Bassi, Gianluigi Li, Fraser, John F., Arora, Rakesh C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942148/
https://www.ncbi.nlm.nih.gov/pubmed/35321649
http://dx.doi.org/10.1186/s12872-022-02565-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942148/
https://www.ncbi.nlm.nih.gov/pubmed/35321649
http://dx.doi.org/10.1186/s12872-022-02565-1

Ejemplares similares